Anabolic androgenic steroid (AAS) and performance-enhancing drug (PED) use is a
prevalent medical issue, especially among men, with an estimated 2.9–4 million Americans …

Additional characterization of patients using anabolic androgenic steroids (AAS) is needed
to improve harm reduction and cessation resources for patients. Our group sought to expand …

Background: Androgenic anabolic steroids (AASs) have a number of licensed clinical
indications but are also subject to abuse within the body building community. They have a …

Anabolic-androgenic steroid (AAS) have widespread and growing illicit use as image and
performance enhancing drugs (IPED), predominantly in young men. Users trying to stop …

Context The lifetime prevalence of anabolic androgenic steroid (AAS) use is estimated at 1%
to 5% worldwide. AAS use occurs primarily male elite athletes and men who want a …

Background A growing body of evidence suggests that anabolic androgenic steroids (AAS)
are used globally by a diverse population with varying motivations. Evidence has increased …

The nonmedical use of anabolic-androgenic steroids (AAS) appeals to athletes across
several sports, particularly those whose activity makes muscle size and strength …

Study Objective To contrast the characteristics of two groups of anabolic‐androgenic steroid
(AAS) users—those with versus those without AAS dependence. Design Subanalysis of data …

Anabolic androgenic steroids (AAS) are performance enhancing drugs commonly used by
athletes and bodybuilders to improve appearance and athletic capability. Unfortunately …

Background Anabolic–androgenic steroids (AAS) mimic the effects of testosterone and may
include testosterone itself; they are used for body enhancement within the general …